08.11.2022 15:00:09

EQS-News: Unicycives Doug Jermasek, EVP-Corporate Development Discusses the Importance of Medication Compliance and the Issues with Pill Burden

EQS-News: Unicycive Therapeautics, Inc.
Unicycives Doug Jermasek, EVP-Corporate Development Discusses the Importance of Medication Compliance and the Issues with Pill Burden

08.11.2022 / 15:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


0.jpgContact Details

Anne Marie Fields - Stern Investor Relations

+1 212-362-1200

annemarie.fields@sternir.com

Company Website

https://unicycive.com/


News Source: News Direct


08.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Unicycive Therapeautics, Inc.
United States
ISIN: US90466Y1038
EQS News ID: 1482189

 
End of News EQS News Service

1482189  08.11.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1482189&application_name=news&site_id=smarthouse

Nachrichten zu Unicycive Therapeutics Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Unicycive Therapeutics Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel